Literature DB >> 2274056

Thyroid hormone regulates type I deiodinase messenger RNA in rat liver.

M J Berry1, A L Kates, P R Larsen.   

Abstract

Conversion of the prohormone T4 to the active hormone T3 is catalyzed by 5'-deiodinases, enzymes that have not been purified. Previous studies have shown that modulating thyroid status results in changes in type I deiodinase activity in the rat liver. We have quantitated type I deiodinase mRNA in liver by an expression assay using Xenopus laevis oocytes. We report here that changes in enzyme activity correlate closely with changes in levels of the mRNA for this enzyme, indicating that thyroid hormone regulates type I deiodinase at a pretranslational step. Using the oocyte system to express size-fractionated mRNA, we have also determined that the mRNA coding for this protein is between 1.9-2.4 kilobases in length. It has been proposed that protein disulfide isomerase (PDI) is closely related to the rat type I 5'-deiodinase. Our results indicate that this is not the case, since injection of in vitro transcribed PDI mRNA into oocytes did not result in expression of deiodinase activity, and the deiodinase mRNA could be physically separated from the 2.8-kilobase mRNA species hybridizing to rat PDI cRNA by size fractionation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274056     DOI: 10.1210/mend-4-5-743

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  19 in total

1.  Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment.

Authors:  Matthew L Rosene; Gábor Wittmann; Rafael Arrojo e Drigo; Praful S Singru; Ronald M Lechan; Antonio C Bianco
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

2.  Epididymis expresses the highest 5'-deiodinase activity in the male reproductive system: kinetic characterization, distribution, and hormonal regulation.

Authors:  Brenda Anguiano; Nuri Aranda; Guadalupe Delgado; Carmen Aceves
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

3.  Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes.

Authors:  J Steinsapir; J Harney; P R Larsen
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

4.  Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones.

Authors:  Laura Sabatino; Valter Lubrano; Silvana Balzan; Claudia Kusmic; Serena Del Turco; Giorgio Iervasi
Journal:  Mol Cell Biochem       Date:  2014-10-11       Impact factor: 3.396

5.  Type 2 iodothyronine deiodinase is highly expressed in human thyroid.

Authors:  D Salvatore; H Tu; J W Harney; P R Larsen
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

6.  No Dataset Left Behind: Mechanistic Insights into Thyroid Receptor Signaling Through Transcriptomic Consensome Meta-Analysis.

Authors:  Scott A Ochsner; Neil J McKenna
Journal:  Thyroid       Date:  2020-01-29       Impact factor: 6.568

7.  The interaction between nuclear receptor corepressor and histone deacetylase 3 regulates both positive and negative thyroid hormone action in vivo.

Authors:  Seo-Hee You; Xiaohui Liao; Roy E Weiss; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2010-04-28

8.  The thyroid hormone receptor alpha1 protein is expressed in embryonic postmitotic neurons and persists in most adult neurons.

Authors:  Karin Wallis; Susi Dudazy; Max van Hogerlinden; Kristina Nordström; Jens Mittag; Björn Vennström
Journal:  Mol Endocrinol       Date:  2010-08-25

9.  Coordinated expression and regulation of deiodinases and thyroid hormone receptors during metamorphosis in the Japanese flounder (Paralichthys olivaceus).

Authors:  Jie Yu; Yuanshuai Fu; Zhiyi Shi
Journal:  Fish Physiol Biochem       Date:  2016-09-12       Impact factor: 2.794

10.  Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.

Authors:  M J Berry; D Grieco; B A Taylor; A L Maia; J D Kieffer; W Beamer; E Glover; A Poland; P R Larsen
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.